Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4317965 | 0.84 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL3864269 | 0.82 | ALDH1A1 (0.44) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL2992405 | 0.81 | HCAR2 (0.38) | ALDH1A1LMNATSHRGAASMN1; SMN2 | |
| SCHEMBL9823358 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL7262 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL1331989 | 0.81 | ALDH1A1 (0.62) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL78520 | 0.81 | DGAT1 (0.46) | ALDH1A1TSHRGAASMN1; SMN2MEN1 | |
| SCHEMBL6131246 | 0.81 | THRB (0.50) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| Tert-Butanol SCHEMBL11267233 | 0.79 | ALDH1A1 (0.48) | ALDH1A1LMNAHSD17B10NPSR1GLO1 | |
| SCHEMBL18213776 | 0.78 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10NPSR1GLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1569803-B | Process for preparing aryl beta-diketo acid | SHANGHAI INST MATERIA MEDICA | 2011-04-13 | — | — | CN | claimed |
| US-6875740-B1 | Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 2005-04-05 | — | — | US | claimed |
| CN-1569803-A | Process for preparing aryl beta-diketo acid | SHANGHAI INST MATERIA MEDICA (CN) | 2005-01-26 | — | — | CN | claimed |
| US-3959312-A | Synthesis of antitumor alkaloid deoxyharringtonine and its precursor 3'-0-(5-methyl-2-oxohexanoyl)-cephalotaxine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1976-05-25 | — | — | US | claimed |
| EP-4638438-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | Xinthera, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| EP-4496787-B1 | THIOL-OXAMIDE COMPOUNDS AND COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-20250100964-A1 | Thiol-Oxamide Compounds and Compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2025-03-27 | — | — | US | disclosed |
| US-20240279214-A1 | ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF | XINTHERA, INC. | 2024-08-22 | — | — | US | disclosed |
| WO-2024138042-A1 | ALPHA4 BETA7 INTEGRIN ANTAGONISTS AND USES THEREOF | XINTHERA, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| CN-115427522-B | Aqueous resin particle dispersion | 爱克发有限公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-4237469-B1 | CURED ADHESIVE COMPOSITIONS AND METHOD OF MAKING | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-116390970-B | Cured adhesive composition and method of making the same | 舒万诺知识产权公司 | 2024-04-26 | — | — | CN | disclosed |
| US-5256798-A | Treating beta-anomer ribofuranosyl sulfonate with source of conjugate anion | ELI LILLY AND COMPANY (US) | 1993-10-26 | — | — | US | disclosed |
| EP-0075600-B1 | 2-THIAZOLEAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL COMPOSITION CONTAINING SAME | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1986-12-30 | — | — | EP | disclosed |
| US-4532137-A | Treating immunodisease by administering immunomodulator | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1985-07-30 | — | — | US | disclosed |
| US-4473577-A | ANTIARTHRITIC AGENTS ANTIINFLAMMATORY AGENTS | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1984-09-25 | — | — | US | disclosed |
| EP-0021676-B1 | 3-METHOXY-2-OXOAZETIDINE DERIVATIVES AND THEIR PRODUCTION | Takeda Chemical Industries, Ltd. (JP) | 1983-09-14 | — | — | EP | disclosed |
| EP-0075600-A1 | 2-THIAZOLEAMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICINAL COMPOSITION CONTAINING SAME | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1983-04-06 | — | — | EP | disclosed |
| US-3959312-A | Synthesis of antitumor alkaloid deoxyharringtonine and its precursor 3'-0-(5-methyl-2-oxohexanoyl)-cephalotaxine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1976-05-25 | — | — | US | disclosed |
| US-3959312-A | Synthesis of antitumor alkaloid deoxyharringtonine and its precursor 3'-0-(5-methyl-2-oxohexanoyl)-cephalotaxine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240279214-A1 | ALPHA4 BETA7 INEGRIN ANTAGONISTS AND USES THEREOF | ITGB7, ITGB4, ITGA4 | ALDH1A1 1190/4885LMNA 3808/4885HSD17B10 3749/4885 |
| US-20250100964-A1 | Thiol-Oxamide Compounds and Compositions | TMT1A, TST, SULT1E1 | ALDH1A1 110/4885LMNA 4510/4885HSD17B10 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.